Halozyme's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Halozyme is scheduled to report earnings on November 7, 2023, and the estimated EPS forecast is $0.74. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 221.04M	$ 162.14M	$ 181.50M	$ 208.98M	$ 152.37M
Gross Profit	$ 170.97M	$ 126.97M	$ 139.38M	$ 161.66M	$ 118.42M
EBIT	$ 97.65M	$ 56.78M	$ 75.36M	$ 81.22M	$ 33.12M
EBITDA	$ 118.68M	$ 74.62M	$ 79.91M	$ 110.42M	$ 45.66M
Net Income Common Stockholders	$ 74.75M	$ 39.62M	$ 57.70M	$ 61.63M	$ 22.68M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 348.27M	$ 275.61M	$ 362.79M	$ 265.58M	$ 209.36M
Total Assets	$ 1.81B	$ 1.70B	$ 1.84B	$ 1.86B	$ 1.78B
Total Debt	$ 1.50B	$ 1.49B	$ 1.51B	$ 1.50B	$ 1.25B
Net Debt	$ 1.15B	$ 1.22B	$ 1.14B	$ 1.24B	$ 1.04B
Total Liabilities	$ 1.66B	$ 1.63B	$ 1.67B	$ 1.77B	$ 1.49B
Stockholders Equity	$ 151.03M	$ 65.85M	$ 169.80M	$ 96.99M	$ 293.17M
Cash Flow	-
Free Cash Flow	$ 68.47M	$ 75.56M	$ 90.09M	$ 68.63M	$ 39.26M
Operating Cash Flow	$ 66.85M	$ 86.94M	$ 82.45M	$ 69.64M	$ 40.23M
Investing Cash Flow	$ 54.99M	$ -60.16M	$ -1.75M	$ -1.01M	$ -434.95M
Financing Cash Flow	$ 2.45M	$ -164.61M	$ 6.33M	$ -12.40M	$ 367.82M

Currency in USD

Halozyme Earnings and Revenue History

Income Statement >

Halozyme Debt to Assets

Balance Sheet >

Halozyme Cash Flow

Cash Flow >

Halozyme Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing